Athersys
ATHX
$0.01350
Share price
-33.50%
Change (1 day)
-98.90%
Change (1 year)
Categories
Athersys (ATHX) - Cash on Hand
Cash on Hand as of September 2023 : $1.02 M
According to Athersys's latest financial reports the company has $1.02 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Athersys - Cash on Hand chart (from 2006 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $9.03 M | -75.84% |
| 2021-12-31 | $37.4 M | -27.43% |
| 2020-12-31 | $51.54 M | 47.1% |
| 2019-12-31 | $35.04 M | -31.37% |
| 2018-12-31 | $51.05 M | 74.17% |
| 2017-12-31 | $29.31 M | 98.71% |
| 2016-12-31 | $14.75 M | -35.93% |
| 2015-12-31 | $23.02 M | -11.87% |
| 2014-12-31 | $26.12 M | -18.22% |
| 2013-12-31 | $31.94 M | 25.12% |
| 2012-12-31 | $25.53 M | 99.73% |
| 2011-12-31 | $12.78 M | -15.79% |
| 2010-12-31 | $15.18 M | -28.73% |
| 2009-12-31 | $21.3 M | -23.95% |
| 2008-12-31 | $28.01 M | -21.59% |
| 2007-12-31 | $35.72 M | |
| 2003-12-31 | $18.9 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 2,247,645.10% | 🇺🇸 USA |
 Pfizer PFE | $12.69 B | 1,244,017.65% | 🇺🇸 USA |
 Amgen AMGN | $10.94 B | 1,072,841.18% | 🇺🇸 USA |
 Sanofi SNY | $9.92 B | 973,247.06% | 🇫🇷 France |
 Merck MRK | $7.09 B | 695,292.16% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $12.28 B | 1,203,821.57% | 🇺🇸 USA |
 Moderna
MRNA | $8.60 B | 843,429.41% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | N/A | 🇺🇸 USA |